Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Dipanjan Banchur

What to Expect From Catalent's Q4 2024 Earnings Report

Catalent, Inc. (CTLT), headquartered in Somerset, New Jersey, enables pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients worldwide. Valued at $10.62 billion by market cap, the company has expertise in development sciences, delivery technologies, and multi-modality manufacturing. It is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. The leading global CDMO is expected to announce its fiscal fourth-quarter earnings for 2024 on Tuesday, Sep. 3.

Ahead of the event, analysts expect CTLT to report a profit of $0.44 per share on a diluted basis, up 388.9% from $0.09 per share in the year-ago quarter. The company missed the consensus estimates in three of the last four quarters while beating on another occasion.  

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.